Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
GV20 Therapeutics Enters into Collaboration with Mitsubishi Tanabe Pharma to Develop Antibody-Drug Conjugates
Thursday, March 27, 2025GV Therapeutics has entered into a research collaboration with Mitsubishi Tanabe Pharma Corporation AntibodyDrug Conjugates ADCs are a class of targeted cancer therapies that combine
MSD Enters into Agreement with Hengrui Pharma for HRS-5346, an Investigational Lipoprotein(a) Inhibitor
Wednesday, March 26, 2025MSD has entered into an exclusive licence agreement with Jiangsu Hengrui Pharmaceuticals for HRS an investigational oral small molecule inhibitor targeting Lipoproteina Lpa
Porosome Therapeutics Unveils Breakthrough in Alzheimer’s Disease Research
Wednesday, March 26, 2025Porosome Therapeutics has announced a significant breakthrough in Alzheimers disease research focusing on secretory dysfunction and new therapeutic approaches Alzheimers disease is characterised by neuronal loss due to secretory and metabolic defects...
Kelun-Biotech’s Radionuclide-Drug Conjugate SKB107 Receives Approval for Bone Metastases Treatment
Wednesday, March 26, 2025Sichuan KelunBiotech Biopharmaceutical has received approval from Chinas National Medical Products Administration NMPA to conduct clinical trials for SKB a radionuclidedrug conjugate RDC developed for treating bone metastases in solid tumors
SineuGene Therapeutics Receives Clearance on SNUG01 for Gene Therapy Targeting Amyotrophic Lateral Sclerosis (ALS) Treatment
Tuesday, March 25, 2025SineuGene Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for SNUG a gene therapy candidate targeting TRIM Tripartite Motif Protein for the treatment of amyotrophic la...
Everest Medicines Receives FDA Clearance for Investigational Cancer Vaccine EVM14
Monday, March 24, 2025Everest Medicines has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for EVM Lung cancer remains one of the most prevalent cancers worldwide with nearly million new cases reported ann...
Novo Nordisk and The United Laboratories International Holdings Limited (TUL) Agreement to Develop UBT251 for Metabolic Disorders
Monday, March 24, 2025Novo Nordisk and The United Laboratories International Holdings Limited TUL have entered into an exclusive licence agreement for UBT a triple receptor agonist targeting GLP GIP and glucagon
Alnylam Secures FDA Approval for AMVUTTRA® (vutrisiran) in Treating Cardiomyopathy
Friday, March 21, 2025Alnylam Pharmaceuticals has received approval from the US Food and Drug Administration FDA for its RNAibased treatment AMVUTTRA vutrisiran ATTRCM is a severe and rapidly progressing condition that affects approximately people in the United States an...
Novartis Secures FDA Approval for Fabhalta® (iptacopan) in C3 Glomerulopathy (C3G) Treatment
Friday, March 21, 2025Novartis has received approval from the US Food and Drug Administration FDA for its oral treatment Fabhalta iptacopan for adults with C glomerulopathy CG CG is a rare and progressive kidney disease that often affects young adults with an average age...
Altesa BioSciences Receives FDA Clearance for Vapendavir to Treat Rhinovirus Infections
Thursday, March 20, 2025Altesa BioSciences has received clearance from the US Food and Drug Administration FDA for its vapendavir treatment for rhinovirus infections in individuals with chronic obstructive pulmonary disease COPD
